Belpointe Asset Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-934
| Closed | -$189K | – | 1142 |
|
|
2023
Q1 | $189K | Sell |
934
-244
| -21% | -$49.2K | 0.01% | 971 |
|
|
2022
Q4 | $257K | Buy |
1,178
+94
| +9% | +$20.5K | 0.02% | 780 |
|
|
2022
Q3 | $213K | Sell |
1,084
-38
| -3% | -$7.47K | 0.01% | 804 |
|
|
2022
Q2 | $240K | Sell |
1,122
-117
| -9% | -$25K | 0.02% | 754 |
|
|
2022
Q1 | $352K | Buy |
1,239
+145
| +13% | +$41.2K | 0.02% | 662 |
|
|
2021
Q4 | $412K | Buy |
1,094
+15
| +1% | +$5.65K | 0.03% | 581 |
|
|
2021
Q3 | $445K | Sell |
1,079
-48
| -4% | -$19.8K | 0.03% | 543 |
|
|
2021
Q2 | $417K | Buy |
1,127
+20
| +2% | +$7.4K | 0.03% | 556 |
|
|
2021
Q1 | $321K | Hold |
1,107
| – | – | 0.03% | 575 |
|
|
2020
Q4 | $277K | Buy |
1,107
+5
| +0.5% | +$1.25K | 0.02% | 582 |
|
|
2020
Q3 | $250K | Sell |
1,102
-514
| -32% | -$117K | 0.03% | 493 |
|
|
2020
Q2 | $282K | Sell |
1,616
-153
| -9% | -$26.7K | 0.04% | 420 |
|
|
2020
Q1 | $223K | Buy |
+1,769
| New | +$223K | 0.04% | 404 |
|